With a fresh £20,000 Stocks and Shares ISA contribution limit at my disposal this April, I turned to ChatGPT to help me build the perfect FTSE 100 portfolio.
I told the artificial intelligence (AI) chatbot I wanted to balance risk and reward with a mix of growth and income stocks across different sectors. While I’d never treat AI as a stock tipper, I was curious to hear its view.
Its first pick is a share I bought last year (but sometimes wish I hadnât): spirits giant Diageo. ChatGPT plucked this from the consumer good sector, describing it as a global drinks powerhouse that “offers solid dividends and pricing power in an inflationary environmentâ.
It admits that the economic slowdown has hit revenues but didnât mention the thing that really worries me â Gen Z isnât so fixated on alcohol. That worries me.
A balanced spread from the FTSE 100
ChatGPTâs second pick is also one I own: insurer and asset manager Legal & General Group, from the financial services sector.
Its shares have idled lately but it does offer a brilliant 8.5% trailing dividend yield. ChatGPT highlights “strong long-term demand for financial planning servicesâ while warning that itâs sensitive to market downturns. I love this one.
AIâs third pick is a share I’ve held in the past, and would like to hold again: Rio Tinto, from the mining and commodities sector. ChatGPT calls it a âreliable dividend payerâ, neglecting to mention that it cut shareholder payouts in 2023. To be fair, it does have a 7% trailing yield today.
Rio Tinto shares have been hit by the struggling Chinese economy and volatile commodity prices. But worth considering at a low valuation of just eight times earnings.
The fourth pick is another stock I hold: Scottish Mortgage Investment Trust, from the technology and growth sector. This has been flying lately, although itâs taken a knock from Chinese AI upstart DeepSeek and Donald Trump’s trade wars. But I canât knock its inclusion as a growth stock, albeit a volatile one.
I also asked ChatGPT to pick one stock it particularly likes. It chose one I don’t hold: pharmaceuticals giant AstraZeneca (LSE: AZN).
AstraZeneca is a top stock, but pricey
Now the UKâs biggest company, my robo-adviser called AstraZeneca the âcornerstoneâ of its ISA portfolio saying: âIt combines resilience with innovation, making it an attractive option for both capital appreciation and stabilityâ.
It said AstraZeneca continues to expand its research and development pipeline and with âblockbuster drugs such as Tagrisso and Imfinzi driving revenues, itâs well-positioned for sustained growthâ.
Drug development’s an expensive and uncertain process and my chatty chum warns: âRegulatory approvals and clinical trial outcomes may influence its successâ. Meanwhile, patent expirations pose a potential threat to revenue streams, requiring a steady flow of new medicines to offset losses, it adds.
Iâm concerned that pharmaceutical companies are in the Trump administration’s firing line, while Astraâs shares aren’t cheap, trading at around 36 times earnings. That’s why I’ve resisted buying.
But I canât argue with ChatGPTâs logic. And I won’t dispute its conclusion that “this portfolio offers a blend of stability, income, and growthâ.
For investors considering how to build a Stocks and Shares ISA, this wouldn’t be a bad start. But they should research the risks as well as the rewards.
The post I asked ChatGPT to build the perfect Stocks and Shares ISA â and here it is! appeared first on The Motley Fool UK.
5 stocks for trying to build wealth after 50
The cost of living crisis shows no signs of slowing… the conflict in the Middle East and Ukraine shows no sign of resolution, while the global economy could be teetering on the brink of recession.
Whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times. Yet despite the stock market’s recent gains, we think many shares still trade at a discount to their true value.
Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…
We’re sharing the names in a special FREE investing report that you can download today. We believe these stocks could be a great fit for any well-diversified portfolio with the goal of building wealth in your 50’s.
Claim your free copy now
More reading
2 FTSE stocks that could do well with the DeepSeek AI breakthrough
3 key reasons why AstraZenecaâs share price looks a steal to me right now
These are my top 3 defensive shares to buy in 2025!
Harvey Jones has positions in Diageo Plc, Legal & General Group Plc, and Scottish Mortgage Investment Trust Plc. The Motley Fool UK has recommended AstraZeneca Plc and Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
